Pharmstandard Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,068

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 5

  • Investments
  • 31

Pharmstandard General Information

Description

Manufacturer of pharmaceutical products based in Dolgoprudny, Russia. The company's products help in the treatment of cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological disorders, metabolic disorders, oncology and a variety of other diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • 5B, Likhachyovsky Proezd
  • Dolgoprudny, 141701
  • Russia
+7 8 (000) 000-00-00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmstandard Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharmstandard‘s full profile, request access.

Request a free trial

Pharmstandard Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products based in Dolgoprudny, Russia. The company's products help in the treatment of ca
Pharmaceuticals
Dolgoprudny, Russia
1,068 As of 2016
00000
00000000000

0. 0.

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
000000000000000
Mumbai, India
0000 As of 0000
0000
000 0000-00-00
000000&0

000 00

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sin
000000000000000
Mumbai, India
00000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharmstandard Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
J. B. Chemicals & Pharmaceuticals Private Equity-Backed Mumbai, India 0000 0000 000000&0
Sun Pharmaceutical Industries Corporation Mumbai, India 00000 000000000000
Casper Pharma Corporate Backed or Acquired East Brunswick, NJ 00 000000&0
Takeda Pharmaceutical Company Corporation Tokyo, Japan 00000 0000 000000000 0000
Angelini Pharma Portugal Corporation Portugal
To view Pharmstandard’s complete competitors history, request access »

Pharmstandard Executive Team (8)

Name Title Board Seat Contact Info
Grigory Potapov Chief Executive Officer & Board Member
Vladimir Chupikov Chief Operating Officer & Board Member
Alexey Chernushkin Chief Investment Officer
You’re viewing 3 of 8 executive team members. Get the full list »

Pharmstandard Board Members (2)

Name Representing Role Since
0000000 0000000 Pharmstandard Chief Executive Officer & Board Member 000 0000
00000000 00000000 Pharmstandard Chief Operating Officer & Board Member 000 0000
To view Pharmstandard’s complete board members history, request access »

Pharmstandard Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharmstandard Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharmstandard‘s full profile, request access.

Request a free trial

Pharmstandard Investments & Acquisitions (31)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nanolek 02-Sep-2022 0000000000 Biotechnology 000000 00
PET-Technology 18-Jul-2018 0000000000 000.00 Clinics/Outpatient Services 000000 00
OncoTartis 11-Dec-2017 00000 0000 000 Drug Discovery
TearSolutions 06-Dec-2017 00000 0000 00.00 Drug Discovery 000000 00
Viriom 06-Dec-2017 Later Stage VC 000.00 Drug Discovery
You’re viewing 5 of 31 investments and acquisitions. Get the full list »

Pharmstandard Subsidiaries (2)

Company Name Industry Location Founded
Nanolek Biotechnology Moscow, Russia 2011
PET-Technology Clinics/Outpatient Services Moscow, Russia 0000
To view Pharmstandard’s complete subsidiaries history, request access »

Pharmstandard Exits (13)

Company Name Exit Date Exit Type Exit Size Status Buyers
Neon Therapeutics 05-Dec-2017 00000 00000 00 00000 Completed
  • 11 buyers
enGene 01-Mar-2017 00000 00000 00 00000 Completed
  • 0000000000000
Protagonist Therapeutics 11-Aug-2016 000 0000 Completed
  • 6 buyers
Argos Therapeutics 28-Jul-2016 0000 0000 Completed
  • 3 buyers
Allena Pharmaceuticals 09-Dec-2015 Later Stage VC 0000 Completed
  • 8 buyers
You’re viewing 5 of 13 exits. Get the full list »

Pharmstandard FAQs

  • When was Pharmstandard founded?

    Pharmstandard was founded in 2003.

  • Who is the CEO of Pharmstandard?

    Grigory Potapov is the CEO of Pharmstandard.

  • Where is Pharmstandard headquartered?

    Pharmstandard is headquartered in Dolgoprudny, Russia.

  • What is the size of Pharmstandard?

    Pharmstandard has 1,068 total employees.

  • What industry is Pharmstandard in?

    Pharmstandard’s primary industry is Pharmaceuticals.

  • Is Pharmstandard a private or public company?

    Pharmstandard is a Private company.

  • What is Pharmstandard’s current revenue?

    The current revenue for Pharmstandard is 000000.

  • How much funding has Pharmstandard raised over time?

    Pharmstandard has raised $880M.

  • Who are Pharmstandard’s investors?

    Bristley Enterprises and Pharmstandard Leksredstva have invested in Pharmstandard.

  • Who are Pharmstandard’s competitors?

    J. B. Chemicals & Pharmaceuticals, Sun Pharmaceutical Industries, Casper Pharma, Takeda Pharmaceutical Company, and Angelini Pharma Portugal are some of the 6 competitors of Pharmstandard.

  • When was Pharmstandard acquired?

    Pharmstandard was acquired on 14-Sep-2016.

  • Who acquired Pharmstandard?

    Pharmstandard was acquired by Augment Investments.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »